Skip to main content

PLEASE NOTE: For everyone’s safety, Fasken recommends anyone on-site at our Canadian offices be familiar with the COVID-19 recommendations in place which may include one or more of the following: social distancing, hand sanitizing, wearing a mask in common areas and proof of full vaccination. These measures apply to lawyers, staff, clients, service providers and other visitors.

Client Work

Vétoquinol acquires the animal health activities of Bioniche Life Sciences

Fasken
Reading Time 1 minute read Subscribe

Overview

Client

Vétoniquol

Vétoquinol acquired the animal health division of Bioniche Life Sciences, a corporation listed on the TSX. This CA$61 million acquisition marks a new step in the deployment of Vétoquinol’s international development strategy and will allow it to strengthen its product portfolio. Vétoquinol is a leader in animal health, both productive livestock (cows, pigs) and house pets (dogs, cats). The Fasken team that accompanied Vétoquinol in this transaction included, among others, Patrice Vachon, Marie-Eve Clavet and Jean-Sébastien Dugas (Corporate/Commercial), Jean-Nicolas Delage and Serge Lapointe (Intellectual Property), Chloé Archambault (Banking), Dan Law (Real Estate), Mathieu Gagné and Jean-Raphaël Champagne (Regulatory Issues), Christian Paquette (Labour) and Jean Michel Lapierre (Securities).

Team

    Subscribe

    Receive email updates from our team

    Subscribe